Stocks / HTFL

Heartflow, Inc. (HTFL) Stock Analysis

Healthcare · Health Information Services · NasdaqGS

Heartflow, Inc. (HTFL) posted $176.03M in revenue for fiscal 2025 (up 39.9% year over year), with a net loss of $116.79M, and has compounded revenue about 42.1%/yr over five years, per its SEC filings.

Data last refreshed August 2, 2026 from SEC filings · how we compute this

Price
$30.82
Market Cap
$2.66B
P/E Ratio
0.00
EPS
$-3.09
Sector
Healthcare
52-Week High
$41.22
52-Week Low
$20.13
Dividend Yield

The analyst's take on Heartflow, Inc.

Heartflow, Inc. has grown revenue from $87.17M to $176.03M over the last 3 fiscal years, compounding about 42.1% a year. The most recent year was up 39.9%, so growth has cooled from its longer-run pace.

Net margin sits at -66.3%, up 10.3 points year over year on a 76.8% gross margin.

The one thing worth a second look in the filings is currently unprofitable.

Synthesised from Heartflow, Inc.'s SEC filings — descriptive, not advice. Ask the analyst your own question →

Heartflow, Inc. revenue & earnings — last 3 fiscal years

Metric202320242025
Revenue$87.17M$125.81M$176.03M
Gross profit$58.05M$94.45M$135.20M
Net income$-95.66M$-96.43M$-116.79M
Net margin-109.7%-76.6%-66.3%

Source: Heartflow, Inc. SEC filings (10-K).

Heartflow, Inc.: 1 potential red flag in the filings

Patterns in the filed statements worth a second look — computed and cited, not AI guesswork, and not a signal to sell. The kind of thing that hides in a 10-K.

Ask the AI to dig into these →

Explore 3 years of Heartflow, Inc. financials — interactive

Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.

Open the interactive view — free

Or start a 7-day free trial to track HTFL in your portfolio →

Heartflow, Inc. financial history by metric

About Heartflow, Inc.

HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company provides Heartflow RoadMap Analysis that offers an intuitive anatomic visualization of the coronary arteries; Heartflow FFRCT Analysis, which calculates blood flow and pinpoints clinically; and Heartflow Plaque Analysis that provides a comprehensive assessment of coronary plaque, enabling optimized medical treatment strategies. Its platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. HeartFlow, Inc. was formerly known as Cardiovascular Simulation, Inc. and changed its name to HeartFlow, Inc. in May 2009. The company was incorporated in 2007 and is headquartered in San Francisco, California.

Heartflow, Inc. — frequently asked questions

What is Heartflow, Inc.'s revenue?

Heartflow, Inc. (HTFL) reported revenue of $176.03M for fiscal year 2025, up 39.9% from the prior year, according to its SEC filings.

Is Heartflow, Inc. profitable?

No — HTFL reported a net loss of $-116.79M in fiscal 2025.

What is HTFL's P/E ratio?

Heartflow, Inc. trades at a price-to-earnings ratio of about 0.0 based on the latest data in our nightly-refreshed cache.

How fast is Heartflow, Inc. growing?

HTFL's revenue grew at roughly 42.1% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.

How much debt does Heartflow, Inc. have?

As of fiscal year 2025, HTFL carried roughly $0 in total debt (short- plus long-term borrowings), per its filed balance sheet.

What is Heartflow, Inc.'s gross margin?

HTFL's gross margin was 76.8% in fiscal 2025 — gross profit of $135.20M on revenue of $176.03M.

What is Heartflow, Inc.'s market cap?

Heartflow, Inc. (HTFL) has a market capitalization of about $2.66B, based on the latest data in our nightly-refreshed cache.

When does Heartflow, Inc.'s fiscal year end?

HTFL's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.

Where does this data come from?

All figures are computed from Heartflow, Inc.'s official SEC filings (10-K and 10-Q), covering 3 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.

Explore more stocks

Browse all 1,500+ companies → · Screen them by fundamentals → · Check earnings quality → · Check share dilution →